You appear to be using an older version of Internet Explorer. We suggest you upgrade your browser for the best viewing experience. Upgrade to a Modern Browser
At the OBN Awards dinner at the Ashmolean Museum in Oxford on 2 October 2014 Adaptimmune won the "Best New Biotech Development Programme" award which was sponsored by J A Kemp. Adaptimmune uses unique genetic engineering technology to create T-cell receptors which target specific cancer cells. In June this year, Adaptimmune announced a strategic collaboration and licensing agreement with GlaxoSmithKline.